|
US2016324992A1
|
|
Identification and treatment of vulnerable plaques
|
|
WO2013032883A2
|
|
Methods of detecting and treating cardiovascular diseases
|
|
US2011124568A1
|
|
Use of heat-shock protein 27 for cardiovascular disease prevention and treatment
|
|
US2009117090A1
|
|
Inhibition of glycogen synthase kinase 3 beta in arterial repair and stent re-endothelialization
|
|
CA2637346A1
|
|
Muscle lamin a/c interacting protein, gene encoding same, and uses therefor
|
|
US2009054340A1
|
|
Use of heat-shock protein 27 for cardiovascular disease prevention and treatment
|
|
CA2562340A1
|
|
A rubidium generator for cardiac perfusion imaging and method of making and maintaining same
|
|
US2007213848A1
|
|
Rubidium elution system control
|
|
US6960472B2
|
|
Monoclonal antibodies against N-Terminus proBNP
|
|
US2003158122A1
|
|
Charged lipid compositions and methods for their use
|
|
US6514523B1
|
|
Carrier particles for drug delivery and process for preparation
|
|
CA2233724A1
|
|
Predicting and detecting cardiac allograft rejection
|
|
CA2229347A1
|
|
Medical suite and x-ray imaging apparatus
|
|
JPH10127772A
|
|
Catheter for closing blood flow, and its usage
|
